Source: OncLive.com As the incidence of head and neck cancers linked to the human papillomavirus (HPV) continues to rise, a federal advisory panel has recommended that all 11- and 12-year-old boys be vaccinated against the virus, igniting further controversy in an area where acceptance of a public health policy has been slow. The recommendation from [...]
Continue reading...Monday, April 2, 2012
Source: Medscape.com Human papillomavirus (HPV) vaccination substantially reduced the risk for subsequent HPV disease in women who already had 1 bout of HPV-related disease, according to a study published online today in BMJ. “These are, to our knowledge, the first results in vaccinated women who have undergone treatment for HPV-related disease,” write the authors, headed [...]
Continue reading...Friday, March 30, 2012
Source: www.news-medical.net Author: staff Research led by Lauren Cole, a public health graduate student, and Dr. Edward Peters, Associate Professor of Public Health and Director of the Epidemiology Program at LSU Health Sciences Center New Orleans, reports that the incidence of head and neck cancer has risen at sites associated with Human Papilloma Virus (HPV) [...]
Continue reading...Tuesday, March 27, 2012
Source: Therapeutics Daily AUSTIN, Texas, March 26, 2012 /PRNewswire-USNewswire/ — Nobel Prize winner Harald zur Hausen called for vaccinating both young males and females for human papilloma virus (HPV) in an achievable quest to eradicate cervical cancer, which is the second leading type of women’s cancer worldwide. Zur Hausen made his remarks at a gathering [...]
Continue reading...Friday, March 23, 2012
Source: AACR News CHICAGO — The American Association for Cancer Research will award Maura L. Gillison, M.D., Ph.D., with the 36th Annual AACR Richard and Hinda Rosenthal Memorial Award during the AACR Annual Meeting 2012, held here March 31 – April 4. Gillison is receiving this award in recognition of her significant contributions to the [...]
Continue reading...Monday, March 19, 2012
Source: www.onclive.com Author: staff Patients with oropharyngeal squamous cell carcinoma who had “matted” lymph nodes — nodes that are connected together — are more likely to metastasize than those without matted lymph nodes, according to a study published online in the journal Head & Neck. Metastases account for about 45% of the deaths among patients [...]
Continue reading...Thursday, March 15, 2012
Source: Dentistry IQ By Maria Perno Goldie, RDH, MS While we should be screening patients for oral and pharyngeal cancer daily, April has been designated as the month when we highlight this disease, and increase awareness about its prevention and treatment. Powerful new technologies that pinpoint the connections between human genes and diseases have clarified [...]
Continue reading...Wednesday, March 14, 2012
Source: Dentistry IQ Mar 14, 2012 By Kevin Henry Managing Editor, Dental Economics Editor’s Note: I recently had the chance to talk with Christine Brader, a former smoker and three-time oral cancer survivor who lives in Allentown, Pa. She is a volunteer senior patient advocate and a board administrator for the Oral Cancer Foundation. For [...]
Continue reading...Wednesday, March 14, 2012
Source: www.onclive.com Author: Ben Leach Approximately 7% of Americans are infected with oral human papillomavirus (HPV), and men are 3 times as likely to be infected as women, according to an analysis that helps define a leading factor in the rise of oropharyngeal cancer. The findings of the HPV prevalence study were presented at the Multidisciplinary Head [...]
Continue reading...Friday, March 9, 2012
Source: Science Daily Researchers at King’s College London and Hiroshima University, Japan, have identified a specific gene linked to throat cancer following a genetic study of a family with 10 members who have developed the condition. The study, published March 8 in the American Journal of Human Genetics, uncovered a mutation in the ATR gene, [...]
Continue reading...
Wednesday, April 18, 2012
0 Comments